() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Cannabis Science

Leading Investment Newsletter Ranks GreenGro Technologies as 10th Most Attractive Stock to Own Out of List of 30 Other Cannabis Securities

Cannabidiol, or CBD, is a component of the marijuana plant. Unlike THC, CBD cannot give you a sense of euphoria or make you intoxicated.  What it can do, however, is provide anti-inflammatory, analgesic, anti-nausea and anti-seizure effects, according to industry experts.  While THC acts on certain cannabinoid receptors found in the brain and central nervous system, CBD works throughout the body.  GreenGro’s strategy all along was to allow the heavyweights, such as GW Pharmaceuticals and Insys Therapeutics, Inc. to spend the millions of research and development dollars it did not have to create the market for smaller yet more agile players such as GreenGro Technologies.  The Company expects to update investors on its latest developments in this arena very shortly.
Read more

Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board

Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has appointed Dr. Joe Wilson, an information technology (IT) and risk management expert, to its International Government Affairs Board (IGAB). For over 20 years, Dr. Wilson has successfully promoted the adoption and use of IT security standards and measurements inside public and private organizations. He has been an active participant with the development of the National Institute of Standards and Technology (NIST) Cybersecurity Framework, and will advise CBIS in a number of areas, including IT security, risk management, blockchain applications, international collaborations, and public/private partnerships
Read more

Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards

Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the Company’s new corporate advisory structure and appoints new leadership for its Scientific Advisory and International Government Affairs Advisory Boards. Dr. Julius Garvey, a renowned vascular surgeon, has been named President of CBIS’ Scientific Advisory Board, and Mr. Jacques Walker, an experienced entrepreneur, has been named President of the Company’s International Government Affairs Advisory Board. Members of the two Corporate Advisory Boards will be announced shortly.
Read more